CCR2 and nasopharyngeal carcinoma: Taking this distinctive occurrence and our findings together, we modestly suggest that, under the circumstance of consecutive and steady administration, inactivating CCL2/CCR2 axis, especially CCR2, would be a promising treatment of NPC.